RMD

Executive Summary ResMed has transitioned from a cyclical medical device manufacturer into a structurally growing digital health platform anchored in…

ResMed Inc (NYSE: RMD) FY 2026 Other Release

ResMed Inc (NYSE: RMD) Q2 2026 Earnings Conference

ResMed Inc (NYSE: RMD) Q2 2026 Earnings Call dated Jan. 29, 2026 Corporate Participants: Sallilyn Schwartz — Chief Investor Relations…

ResMed Inc (NYSE: RMD) Q2 2025 Earnings Call dated Jan. 30, 2025 Corporate Participants: Mike Ott — Senior Manager, Investor…

ResMed Inc (NYSE: RMD) Q3 2025 Earnings Call dated Apr. 23, 2025 Corporate Participants: Michael Farrell — Chief Executive Officer…

ResMed Inc (NYSE: RMD) Q4 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Salli Schwartz — Chief Investor Relations…

ResMed Inc (NYSE: RMD) Q1 2026 Earnings Call dated Oct. 30, 2025 Corporate Participants: Sallilyn Schwartz — Chief Investor Relations…

ResMed Inc (NYSE: RMD) Q3 2022 Earnings Conference

ResMed inc (NYSE: RMD) Q2 2022 Earnings Conference